A new treatment that uses genetic manipulation to tailor genes and create modified immune cells programmed to seek out and destroy drug-resistant leukemia has been used in a hospital in the UK A three-month-old baby girl diagnosed with an aggressive form of bone marrow cancer called acute lymphoblastic leukemia, given a cycle of chemotherapy, a bone marrow transplant, became a part of a clinical trial all before her first birthday- but cancer relapsed! As doctors knew the success rate for such aggressive form of this disease at this age is not more than 25%, doctors lost all hope and was preparing for her to perish. But doctors wanted to try one last option as they have heard about Dr.
Waseem Qasim of University College London, who was working on a specific mode of gene therapy to treat cancer. The therapy involved creating a modified immune cell with an ability to attack cancerous…
